Abstract-The
CAMP was demonstrated to suppress neoplastic Bcell proliferation in human and murine lymphoma cell lines [30, 31] . We therefore conducted a study to determine the number and affinity of & adrenoceptors on normal and malignant human lymphocytes and to investigate the function of the &adrenergic signal transduction (receptor, G,, AC) in these cells by stimulation with different agents (isoproterenol, cholera toxin and forskolin).
MATERIALS AND METHODS
Patients. Fifteen patients with leukemic low grade non-Hodgkin lymphoma (lymphocyte count > 10' cells/pL) aged from 48 to 79 years (median 68 years; mean f SD 63.5 L 10.5 years; seven female eight male) treated in the Medizinische Klinik, Klinikum Innenstadt, Munich, Germany, entered the study. Six apparently healthy subjects and one patient with coronary heart disease without further complications or treatment, aged from 24 to 78 years (median 33; mean 2 SD 42.8 2 20.7; two female, 5 male) served as controls. The histopathological entities according to the Kiel classification [32] were distributed as follows: 12 CLL, two immunocytoma (IC) and one centrocytic-centroblastic lymphoma (cccb). Immunophenotyping of mononucIear leucocytes (MNL) in patients showed that all were Bcell lymphoma, and that more than 90% of MNL were B-cells. CLL and IC patients were staged according to the Binet classification [33] , the cccb patient according to the Ann Arbor classification [34] . Three of the 14 CLL and IC patients were in Binet stage A, six in stage B and five in stage C. Binding assny. The experimental procedure was performed as described previously [35] . with small modifications.
Briefly, samples of 15-20 mL heparinized, venous blood were obtained between 9 and 10 a.m. MNL were harvested by density gradient centrifugation [36] . The MNL fraction was washed twice in HH pH 7.4 and then resuspended in this buffer. Intact cells (5 x 10') were incubated in 100 PL with varying concentrations (1.0-180 pmol/ L) of "'ICYP for 120min at 37" to determine total binding (TB). Unspecific binding (UB) was determined in parallel incubations with 1 /Imol/L unlabelled (-)timolol.
Specific binding was defined as TB -UB. After the incubation period, the samples were centrifuged at 15,000 g for 5 min and the supernatant was removed by suction. The pellets were counted in a Packard Gamma Spectrometer (model 5360).
Specific binding data were iteratively fitted by non-linear regression analysis to a model of two independent binding sites as described earlier [35, 37] , using the Enzfitter program from Biosoft@. Cambridge, U.K. This model was used because previous studies in our own laboratory, as well as in other laboratories, suggested the existence of two rather than one binding site for /$-adrenoceptors on human MNL [35, 37, 38] .
Binding data were also plotted according to the method of Scatchard [39] in order to visualize results. Since the functional and molecular properties of the low affinity binding site are yet to be defined, only the results for the high affinity binding site were considered, and the high affinity binding site was called &adrenoceptor. Kn and B,,, represented the equilibrium dissociation constant and density of the high affinity binding site in the saturation experiments.
Stimulation of AC andcAMP assay. MNL (5 X lo5 in SOOpL) were preincubated for 30min at 20" in the presence of 10-3mol/L IBMX to inhibit phosphodiesterase activity. Thereafter, the cells were incubated at 37" with isoproterenol (0, 1O-x. 5 X 10m7 and lo-" mol/L) for 10 min. cholera toxin (0,lOV and lo-" /mL) for 60 or 120 min, or forskolin (10m4 mol P L) for 15 min. Isoproterenol was diluted in HH buffer, cholera toxin in distilled water, and forskolin in 100% ethanol (control experiments with ethanol revealed no influence on cAMP accumulation).
The reaction was stopped by incubating the ceils at 100" for 5 min. Thereafter, the cells were centrifuged at 15.000 g, 300 ILL of the The apparent affinity constant (&) exhibited no significant difference (Fig. 2 ).
Stimulation of AC by different agents
The basal CAMP accumulation of normal lymphocytes and lymphoma cells showed no difference and did not significantly change within the incubation periods used (l&120 min). The intracellular CAMP accumulation after incubation with 10e4 mol/L isoproterenol was slightly lower in lymphoma cells (12.0 ? 2.0 pmol/lOh cells) as compared with normal lymphocytes (18.9 t 4.4 pmol/106 cells; P = 0.06). At lower concentrations of isoproterenol, the difference in CAMP accumulation between normal and malignant lymphocytes decreased. Cholera toxin increased the intracellular CAMP levels in normal and malignant lymphocytes to the same extent (for all concentrations and incubation periods used); these results, however, showed a considerable interindividual variation, particularly in lymphoma patients as demonstrated by large SEM ranges. Forskolin increased the intracellular CAMP accumulation of lymphoma cells to 22.3 t 3.3 pmol/106 cells (Fig. 3) . In normal lymphocytes, this increase was about g-fold higher (163.3 -C 25.9 pmol/106 cells; P < 0.01). All results were checked for correlations with age of patients and controls without any significant result.
DISCUSSION
In agreement with previous investigations [ 18-201 this study shows that the number of high affinity aadrenergic binding sites is decreased in human low grade lymphoma cells as compared with normal lymphocytes (Figs. 1 and 2) . The 3-fold lower density of &-adrenoceptors in malignant B-cells can neither be explained by age differences [41] nor by the elevated B-: T-cell ratio in lymphoma patients as compared with normal donors, because normal Bcells bear more /$,-adrenoceptors than T-cells [20, 42, 43] .
The responsiveness of AC to isoproterenol was only slightly decreased in MNL of lymphoma patients (Fig. 3) . The function of the stimulating G protein, G,, seemed to be conserved in the malignant B-cells as demonstrated by the experiments with cholera toxin (Fig. 3) . These results correspond well to similar experiments on CLL lymphocytes using NaF, another stimulator of G, [14, 181. Finally, the most relevant finding of this study was that the AC response to forskolin was considerably impaired in the malignant B-cells (Fig. 3) .
The results should be interpreted with caution because of the lack of investigations on the effect of forskolin in subpopulations of normal lymphocytes. However, the responsiveness of AC to a variety of compounds (isoproterenol, NaF, GTP and prostaglandin E,) was shown to be higher in Blymphocytes than in T-lymphocytes [20] . Therefore, it does not seem probable that the decreased AC responsiveness to forskolin in malignant B-cells may be explained by the only difference of B-and Tcells. With these limitations in mind, it can be concluded from our experiments that the aadrenergic signal transduction in malignant human B-cells seems to be impaired, above all at the AC level. Additionally, the density of &adrenoceptors is decreased. Both phenomena may account for decreased intracellular CAMP levels in these cells [17, 20] , thereby contributing to their malignant transformation [13, 17,22-281. In this context, Inhorn et al. [28] demonstrated that the restoration of the AC responsiveness to forskolin, cholera toxin and prostaglandin El by butyrate was responsible for the antiproliferative effects of these compounds in a murine myeloid cell line. The same authors provided evidence that an imbalance between the inhibitory G protein, Gi, and the stimulatory G protein, G,, might be responsible for the decreased AC activity of this cell line. Alterations of this balance and/or functional changes of Gi would also help to explain the impairment of the AC responsiveness to forskolin observed in this study in lymphoma cells. The AC might be permanently inhibited by an absolute or relative increase of the activity of Gi [44] . Other explanations include the permanent inhibition of AC by protein Basal activity IS0 le-6 mol/l IS0 le-4 molil CHO le-6 g/ml CHO le.4 g/ml FK 1 e-4 mol/l kinase C known to be stimulated by different cytokines and (tumor) growth factors [45] , mutations of AC at its catalytic or regulatory sites, a reduction of AC synthesis, or an increase of AC metabolism. However, increased inhibitory effects on AC, or changes of the catalytic subunit of AC do not explain by themselves that the stimulation of AC by isoproterenol and cholera toxin, though taking place upstream in the signal transduction pathway, seems to be less impaired than the direct AC stimulation with forskolin. One could expect that an impairment of AC should affect the signal transduction pathway to a similar extent at all levels upstream. Our experiments, however, showed no evidence that the AC impairment, as reflected by a significantly reduced responsiveness to forksolin, is necessarily paralleled by a similar decrease of its response to isoproterenol and cholera toxin in lymphoma cells. Therefore, a compensatory mechanism upstream of AC might balance the AC impairment to some extent. In our experiments, the &adrenoceptor number was decreased, and the receptor affinity was not changed in lymphoma cells. Therefore, an increase of the receptor density or affinity does not seem to compensate the AC impairment. The slightly, but not significantly increased CAMP accumulation in lymphoma cells in response to cholera toxin (Fig. 3) rather supports the hypothesis that the induction of more functional G, molecules could contribute to this compensation.
However, this compensation seems to disappear with disease progression and increasing tumor cell proliferation, since the ability of cholera toxin to stimulate lymphocyte AC was found to decrease significantly with disease progression in CLL and IC patients (Hallek et al., unpublished data).
The most satisfactory explanation derives from the comparison with cell line mutants defective in AC related signal transduction.
Those cell lines, particularly S49 lymphoma mutants. proved to be powerful tools for studying the interaction between receptors, G proteins and AC [4&48] . Forksolinresistant mutants of Yl adrenocortical tumor cells [49] share some common features with our findings in lymphoma cells, and therefore merit close comparison.
These mutants had a decreased responsiveness of AC to forskolin. and, though to a lesser extent, to ACTH (via the receptor) and to Gpp(NH)p. a non-hydrolysable GTP analogue. On the contrary, AC was normally stimulated by NaF (via G,) . Since the cholera toxin-mediated incorporation of ['*PINAD to the N subunit of G, ((u,) was reduced by 70%, a defect of a; was suggested. a; is the regulatory subunit of the G, heterotrimer that stimulates the catalytic unit of AC [44] . It seems to be required for the full stimulation of AC by forskolin, although forskolin is able to activate AC in the absence of functional active G, to some extent [47] . The observations on Y 1 mutants show similarities to the impairment of &adrenergic signal transduction reported in this study, where the CAMP accumulation was particularly decreased in response to forskolin, and to a lesser extent to isoproterenol (via the receptor) and cholera toxin (via G,) (Fig. 3) . They provide a model in which the functionally active subunit of G,, cr,, rather than the catalytic unit of AC is altered. These alterations might account for the impairment of the /3-adrenergic signal transduction pathway in human B-cell lymphoma .
These findings await further investigations involving the use of monoclonal antibodies against AC and subunits of G proteins for quantitation by Western blotting, the study of different transmembrane signal pathways inhibiting AC, and the molecular analysis of the subunits of G, and AC in human lymphoma cells. Further studies of the p2-adrenergic signal transduction in lymphoma cells, with emphasis on the effects of forskolin, are under way. They may improve our understanding of the pathogenesis of lymphoma and help to develop new therapeutic strategies based on modifying the AC activity in lymphoma cells.
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